Vicky Huang - Concepedia

Author

Vicky Huang

Kelowna General Hospital

Also Known As

Vicky Huang, Vicky W Huang, Vicky W. Huang, Vicky W.‐H. Huang, Vicky Wei-Hsuen Huang

Publications

536

Citations

H-Index

Concepts

All Affiliations

Kelowna General Hospital Positive Living North University of British Columbia Saskatchewan Cancer Agency Hospital Pulau Pinang

About

Vicky Huang is an author at Kelowna General Hospital specializing in medicine, clinical trials, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	179
2	Health Sciences	2	2	105
3	Engineering	1	1	22
4	Natural Sciences	1	1	22
5	Biomolecular Engineering	1	1	49

Vicky Huang

Publications

479

Citations

H-Index

Page 1

	Year	Citations
Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers Jordan Wong, Vicky Huang, Derek Wells, Radiation Oncology	2021	83
New film‐coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower‐risk MDS: Results of the randomized, phase II ECLIPSE study Alì Taher, Raffaella Origa, Silverio Perrotta, American Journal of Hematology Pharmaceutical ScienceTablet FormulationPharmacotherapyPharmacokineticsPre-clinical Pharmacology	2017	77
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer Robert Olson, Will Jiang, Mitchell Liu, JAMA Oncology	2022	61
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease Yu-Chih Liu, Vicky Huang, Ti-Chun Chao, Biochemical and Biophysical Research Communications MedicineDrug DiscoverySars-cov 3ClAntiviral Drug DevelopmentAntiviral Drug	2005	49
Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours Jordan Wong, Vicky Huang, Joshua Giambattista, Frontiers in Oncology	2021	30
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial Reno Eufemon Cereno, Benjamin Mou, Sarah Baker, Radiotherapy and Oncology Adaptive RadiotherapyRadiation MedicineRadiation TherapyTarget Volume CoverageMedicine	2023	28
Dosimetry with a clinical linac adapted to FLASH electron beams Stanislaw Szpala, Vicky Huang, Yingli Zhao, Journal of Applied Clinical Medical Physics	2021	26
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial Matthew Van Oirschot, Alanah Bergman, Wilko F.A.R. Verbakel, International Journal of Radiation OncologyBiologyPhysics Disease ManagementClinical TrialsSurgerySecondary AnalysisMedicine	2022	25
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias Alì Taher, Raffaella Origa, Silverio Perrotta, Health and Quality of Life Outcomes	2018	24
Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta‐thalassemia in Taiwan: A real‐world analysis Chao‐Hsiun Tang, Wesley Furnback, Bruce C. M. Wang, Transfusion	2021	24

Page 1